Global Histone Deacetylase 1 Market Research Report 2012-2024
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 RCY-1305
- 1.2.1.2 HG-3001
- 1.2.1.3 CS-3158
- 1.2.1.4 ACY-957
- 1.2.1.5 ST-3595
- 1.2.1.6 Others
- 1.2.2 by Application
- 1.2.2.1 Alopecia
- 1.2.2.2 Endometrial Cancer
- 1.2.2.3 Myelofibrosis
- 1.2.2.4 Neurology
- 1.2.2.5 Skin Cancer
- 1.2.2.6 Others
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 RCY-1305 Market, 2013-2018
- 4.1.2 HG-3001 Market, 2013-2018
- 4.1.3 CS-3158 Market, 2013-2018
- 4.1.4 ACY-957 Market, 2013-2018
- 4.1.5 ST-3595 Market, 2013-2018
- 4.1.6 Others Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 RCY-1305 Market Forecast, 2019-2024
- 4.2.2 HG-3001 Market Forecast, 2019-2024
- 4.2.3 CS-3158 Market Forecast, 2019-2024
- 4.2.4 ACY-957 Market Forecast, 2019-2024
- 4.2.5 ST-3595 Market Forecast, 2019-2024
- 4.2.6 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Alopecia Market, 2013-2018
- 5.1.2 Endometrial Cancer Market, 2013-2018
- 5.1.3 Myelofibrosis Market, 2013-2018
- 5.1.4 Neurology Market, 2013-2018
- 5.1.5 Skin Cancer Market, 2013-2018
- 5.1.6 Others Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Alopecia Market Forecast, 2019-2024
- 5.2.2 Endometrial Cancer Market Forecast, 2019-2024
- 5.2.3 Myelofibrosis Market Forecast, 2019-2024
- 5.2.4 Neurology Market Forecast, 2019-2024
- 5.2.5 Skin Cancer Market Forecast, 2019-2024
- 5.2.6 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 4SC AG
- 8.2 Acetylon Pharmaceuticals, Inc.
- 8.3 Chipscreen Biosciences Ltd
- 8.4 Curis, Inc.
- 8.5 GlaxoSmithKline Plc
- 8.6 HitGen LTD
- 8.7 IRBM Science Park SpA
- 8.8 Italfarmaco S.p.A.
- 8.9 MEI Pharma, Inc.
- 8.10 Merck & Co., Inc.
- 8.11 Mirati Therapeutics Inc.
- 8.12 Oncolys BioPharma Inc.
- 8.13 Sigma-Tau S.p.A.
- 8.14 Syndax Pharmaceuticals, Inc.
- 8.15 TetraLogic Pharmaceuticals
9 Conclusion
Summary
The global Histone Deacetylase 1 market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
RCY-1305
HG-3001
CS-3158
ACY-957
ST-3595
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
4SC AG
Acetylon Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Curis, Inc.
GlaxoSmithKline Plc
HitGen LTD
IRBM Science Park SpA
Italfarmaco S.p.A.
MEI Pharma, Inc.
Merck & Co., Inc.
Mirati Therapeutics Inc.
Oncolys BioPharma Inc.
Sigma-Tau S.p.A.
Syndax Pharmaceuticals, Inc.
TetraLogic Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Alopecia
Endometrial Cancer
Myelofibrosis
Neurology
Skin Cancer
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa